Salarius Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor.
SLRX Key Statistics
Stock Snapshot
As of today, Salarius Pharmaceuticals(SLRX) shares are valued at $0.54. The company's market cap stands at 4.25M, with a P/E ratio of -0.02.
During the trading session on 2026-01-02, Salarius Pharmaceuticals(SLRX) shares reached a daily high of $0.69 and a low of $0.50. At a current price of $0.54, the stock is +7.4% higher than the low and still -21.7% under the high.
Trading activity shows a volume of 431.96K, compared to an average daily volume of 223.56K.
Over the past 52 weeks, Salarius Pharmaceuticals(SLRX) stock has traded between a high of $108.00 and a low of $0.50.
Over the past 52 weeks, Salarius Pharmaceuticals(SLRX) stock has traded between a high of $108.00 and a low of $0.50.
SLRX News
Claim 70% Off TipRanks This Holiday Season The latest announcement is out from Salarius Pharmaceuticals ( (SLRX) ). On December 31, 2025, Salarius Pharmaceuti...